Growth of incidental meningiomas

Acta Neurochirurgica

Volumn 142, Issue 5, 2000, Pages 507-511

  Yoneoka, Y ^a   Fujii, Y ^a   Tanaka, R ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Growth rate; Incidental tumour; Meningioma; Multivariate analysis

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REGRESSION ANALYSIS; TUMOR GROWTH; TUMOR VOLUME;

EID: 0034065524     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010050463     Document Type: Article

References (19)

1. 1. Abramovich CM, Prayson RA (1998) MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. Hum Pathol 29: 1420-1427
2. 2. Firsching RP, Fischer A, Peters R, Thun F, Klug N (1990) Growth rate of incidental meningiomas. J Neurosurg 73: 545-547
3. 3. Hsu DW, Efird JT, Hedley-Whyte ET (1998) MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas. Neuropathol Appl Neurobiol 24: 441-452
4. 4. Ide M, Jimbo M, Yamamoto M, Umebara Y, Hagiwara S; Kubo O (1996) MIB-1 staining index and peritumoral brain edema of meningiomas. Cancer 78: 133-143 1996
5. 5. Jääskeläinen J, Haltia M, Laasonen E, Wahlström T, Valtonen S (1985) The growth rate of intracranial meningiomas and its relation to histology: an analysis of 43 patients. Surg Neurol 24: 165-172
6. 6. Kakinuma K, Tanaka R, Onda K, Takahashi H (1998) Proliferative potential of recurrent intracranial meningiomas as evaluated by labeling indices of BUdR and Ki-67, and tumour doubling time. Acta Neurochir (Wien) 140: 26-32
7. 7. Karamitopoulou E, Perentes E, Tolnay M, Probst A (1998) Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 29: 140-145
8. 8. Maier H, Wanschitz J, Sedivy R, Rössler K, Ofner D, Budka H (1997) Proliferation and DNA fragmentation in meningioma subtypes. Neuropathol Appl Neurobiol 23: 496-506
9. 9. Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, Matsuura R, Utsunomiya H, Kirino T (1996) Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol (Berl) 91: 504-510
10. 10. Matsuno A, Nagashima T, Matsuura R, Tanaka H, Hirakawa M, Murakami M, Tamura A, Kirino T (1996) Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. Am J Clin Pathol 106: 776-781
11. 11. Nagashima G, Aoyagi M, Yamamoto M, Yamamoto S, Wakimoto H, Ohno K, Yamamoto K, Hirakawa K (1999) P53 overexpression and proliferative potential in malignant meningiomas. Acta Neurochir (Wien) 141: 53-61
12. 12. Nakagawa Y, Sugawa N, Ueda S, Suzuki K, Vignutelli A, Perentes E (1997) Measurement of cell kinetic parameters in meningiomas. Neurol Med Chir (Tokyo) 37: 12-17
13. 13. Nakaguchi H, Fujimaki T, Matsuno A, Matsuura R, Asai A, Suzuki I, Sasaki T, Kirino T (1999) Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry Cancer 85: 2249-2254
14. 14. Nakasu S, Nakasu Y, Nakajima M, Yokoyama M, Matsuda M, Handa J (1996) Potential doubling time and tumour doubling time in meningiomas and neurinomas. Acta Neurochir (Wien) 138: 763-770
15. 15. Ohkoudo M, Sawa H, Hara M, Saruta K, Aiso T, Ohki R, Yamamoto H, Maemura E, Shiina Y, Fujii M, Saito I (1998) Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas. J Neurooncol 38: 41-49
16. 16. Olivero WC, Lister JR, Elwood PW (1995) The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 83: 222-224
17. 17. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82: 2262-2269
18. 18. Rausing A, Ybo W, Stenflo J (1970) Intracranial meningioma -a population study of ten years. Acta Neurol Scand 46: 102-110
19. 19. Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82: 2262-2269